Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
A marker strongly associated with outcome (or disease) is often assumed to be effective for classifying persons according to their current or future outcome. However, for this assumption to be true, the associated odds ratio must be of a magnitude rarely seen in epidemiologic studies. In this paper, an illustration of the relation between odds ratios and receiver operating characteristic curves shows, for example, that a marker with an odds ratio of as high as 3 is in fact a very poor classification tool. If a marker identifies 10% of controls as positive (false positives) and has an odds ratio of 3, then it will correctly identify only 25% of cases as positive (true positives). The authors illustrate that a single measure of association such as an odds ratio does not meaningfully describe a marker's ability to classify subjects. Appropriate statistical methods for assessing and reporting the classification power of a marker are described. In addition, the serious pitfalls of using more traditional methods based on parameters in logistic regression models are illustrated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, for diagnostic, prognostic, or screening markers in epidemiologic studies, the limited magnitude of the OR considered meaningful (i.e., about or >70) is rarely discussed (36).”
From Misrepresentation and distortion of research in biomedical literature (2018) · cites this paper as [36]
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“Examples include the Framingham risk score for cardiovascular events (2) and the Gail model risk score for breast cancer (3).”
BackgroundA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“Examples from other popular journals are Ridker et al. ( 11 ), Zhang et al. (12), Liou et al. (13), and Hogue et al. (14).”
BackgroundGail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
The Statistical Evaluation of Medical Tests for Classification and Prediction
(2005) · Technometrics · doi:10.1198/tech.2005.s278 · Cited by 1,899
Self-citationCarney, P. A., Miglioretti, D. L., Yankaskas, B. C., Kerlikowske, K., Rosenberg, R., Rutter, C. M., Geller, B. M., Abraham, L. A., Taplin, S. H., Dignan, M., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00008 · Cited by 1,142
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data
WIEAND, S., GAIL, M. H., JAMES, B. R., & JAMES, K. L. (1989) · Biometrika · doi:10.1093/biomet/76.3.585 · Cited by 355
Cited by
Items 401–500 of 1,000
Sun, J., Kader, A. K., Hsu, F., Kim, S., Zhu, Y., Turner, A. R., Jin, T., Zhang, Z., Adolfsson, J., Wiklund, F. E., et al. (2010) · The Prostate · doi:10.1002/pros.21256 · Cited by 49
Giannoni, A., Baruah, R., Leong, T., Rehman, M. B., Pastormerlo, L. E., Harrell, F. E., Coats, A. J. S., & Francis, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0081699 · Cited by 49
Grellety, E., & Golden, M. H. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0384-4 · Cited by 49
Elbaum, B. E., Gattamorta, K. A., & Penfield, R. D. (2010) · Journal of Early Intervention · doi:10.1177/1053815110384723 · Cited by 49
Calibrating parametric subject-specific risk estimation
Cai, T., Tian, L., Uno, H., Solomon, S. D., & Wei, L. J. (2010) · Biometrika · doi:10.1093/biomet/asq012 · Cited by 48
Tereshchenko, L. G., Cheng, A., Fetics, B. J., Butcher, B., Marine, J. E., SPRAGG, D. D., Sinha, S. K., Dalal, D., Calkins, H. G., Tomaselli, G. F., et al. (2010) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2010.08.012 · Cited by 48
Fisk, S. A., Lindström, M., Vicente, R. P., & Merlo, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042323 · Cited by 48
Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma
Chang, Y.-H., Chen, C., Chen, H., & Yang, P. (2015) · Scientific Reports · doi:10.1038/srep10979 · Cited by 47
Raifu, A. O., El‐Zein, M., Sangwa‐Lugoma, G., Ramanakumar, A. V., Walter, S. D., Franco, E. L., & For the Congo Screening Study Group (2017) · PLoS ONE · doi:10.1371/journal.pone.0170631 · Cited by 47
Standards for Reporting Prognostic Tumor Marker Studies
Alonzo, T. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3778 · Cited by 47
Sevini, F., Giuliani, C., Vianello, D., Giampieri, E., Santoro, A., Biondi, F., Garagnani, P., Passarino, G., Luiselli, D., Capri, M., et al. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.03.022 · Cited by 46
Risk, Prognosis, and Unintended Consequences in Kidney Allocation
Hippen, B. E., Thistlethwaite, J. R., & Ross, L. F. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1102583 · Cited by 46
Richardsen, K. R., Falk, R. S., Jenum, A. K., Mørkrid, K., Martinsen, E. W., Ommundsen, Y., & Berntsen, S. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0985-x · Cited by 46
Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression
Frankenstein, Z., Basanta, D., Franco, O. E., Gao, Y., Javier, R., Strand, D. W., Lee, M., Hayward, S. W., Ayala, G., & Anderson, A. R. A. (2020) · Nature Ecology & Evolution · doi:10.1038/s41559-020-1157-y · Cited by 46
Visualizing Risk Prediction Models
Van Belle, V., & Van Calster, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132614 · Cited by 46
Research translation: a new frontier for clinical laboratories
Plebani, M., & Marincola, F. M. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.238 · Cited by 46
Dallmeier, D., Larson, M. G., Wang, N., Fontes, J. D., Benjamin, E. J., & Fox, C. S. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000869 · Cited by 45
Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease
Srinivasan, B. S., Doostzadeh, J., Absalan, F., Mohandessi, S., Jalili, R., Bigdeli, S., Wang, J. L., Mahadevan, J., Lee, C. G. L., Davis, R. W., et al. (2008) · Human Mutation · doi:10.1002/humu.20840 · Cited by 46
Sigurdson, A. J., Brenner, A. V., Roach, J. A., Goudeva, L., Müller, J. A., Nerlich, K., Reiners, C., Schwab, R., Pfeiffer, L., Waldenberger, M., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw047 · Cited by 45
Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients
Geboers, D. G. P. J., de Beer, F. M., Boer, A. M. T., van der Poll, T., Horn, J., Cremer, O. L., Bonten, M. J. M., Ong, D. S. Y., Schultz, M. J., & Bos, L. D. J. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3924-9 · Cited by 45
Predictive accuracy in the neuroprediction of rearrest
Aharoni, E., Mallett, J. S., Vincent, G. M., Harenski, C. L., Calhoun, V. D., Sinnott-Armstrong, W. P., Gazzaniga, M. S., & Kiehl, K. A. (2014) · Social Neuroscience · doi:10.1080/17470919.2014.907201 · Cited by 45
Svenningsen, R., Borstad, E., Spydslaug, A., Sandvik, L., & Staff, A. C. (2012) · International Urogynecology Journal · doi:10.1007/s00192-012-1764-5 · Cited by 45
Ho, H., Cheung, C. Y.-L., Sabanayagam, C., Yip, W., Ikram, M. K., Ong, P. G., Mitchell, P. L. R., Chow, K. Y., Cheng, C., Tai, E. S., et al. (2017) · Scientific Reports · doi:10.1038/srep41492 · Cited by 45
Utility of genetic determinants of lipids and cardiovascular events in assessing risk
Holmes, M. V., Harrison, S., Talmud, P. J., Hingorani, A. D., & Humphries, S. E. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.6 · Cited by 44
“Measures of effect size from case-control studies include the proportion of variance explained as well as the odds ratio”
BackgroundRates and Prediction of Successful Vaginal Birth After Cesarean
Grobman, W. A. (2010) · Seminars in Perinatology · doi:10.1053/j.semperi.2010.03.003 · Cited by 44
Cabassi, A., de Champlain, J., Maggiore, U., Parenti, E., Coghi, P., Vicini, V., Tedeschi, S., Cremaschi, E., Binno, S. M., Rocco, R., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.039 · Cited by 44
The role of ethnicity in predicting diabetes risk at the population level
Rosella, L. C., Mustard, C., Stukel, T. A., Corey, P., Hux, J. E., Roos, L. L., & Manuel, D. G. (2012) · Ethnicity and Health · doi:10.1080/13557858.2012.654765 · Cited by 44
Anthropometric Predictors of Incident Type 2 Diabetes Mellitus in Iranian Women
Hadaegh, F., Shafiee, G., & Azizi, F. (2009) · Annals of Saudi Medicine · doi:10.5144/0256-4947.51788 · Cited by 44
Understanding increments in model performance metrics
Pencina, M. J., D’Agostino, R. B., & Massaro, J. M. (2012) · Lifetime Data Analysis · doi:10.1007/s10985-012-9238-0 · Cited by 43
Incremental Value of Polygenic Risk Scores in Primary Prevention of Coronary Heart Disease: A Review
Groenendyk, J. W., Greenland, P., & Khan, S. S. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.3171 · Cited by 40
Brown, E. R., Otieno, P. A., Mbori‐Ngacha, D., Farquhar, C., Obimbo, E. M., Nduati, R. W., Overbaugh, J., & John-Stewart, G. C. (2009) · The Journal of Infectious Diseases · doi:10.1086/597617 · Cited by 43
Methods for evaluating novel biomarkers - a new paradigm: Perspective
Cook, N. R. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02469.x · Cited by 37
Mannan, H. R., Stevenson, C., Peters, A., Walls, H., & McNeil, J. J. (2010) · Heart International · doi:10.4081/hi.2010.e11 · Cited by 43
A New PCR-Based Mass Spectrometry System for High-Risk HPV, Part I
Yi, X., Li, J., Yu, S., Zhang, A., Xu, J., Yi, J. S., Zou, J., Nie, X., Huang, J., & Wang, J. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpwtzdt0q7dovi · Cited by 42
Charlton-Menys, V., Betteridge, D. J., Colhoun, H. M., Fuller, J., France, M. W., Hitman, G. A., Livingstone, S. J., Neil, H. A. W., Newman, C. B., Szarek, M. J., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1176-8 · Cited by 42
Tawa, N., Rhoda, A. J., & Diener, I. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1236-z · Cited by 42
Charpentier, S., Maupas‐Schwalm, F., Cournot, M., Elbaz, M., Botella, J. M., & Lauque, D. (2012) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2012.01350.x · Cited by 41
Assessing the Value of Customized Birth Weight Percentiles
Hutcheon, J. A., Walker, M., & Platt, R. W. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq399 · Cited by 41
Lin, J. S., Webber, E. M., Senger, C. A., Holmes, R. S., & Whitlock, E. P. (2011) · PubMed · Cited by 42
Consenso de Prediabetes. Documento de posición de la Asociación Latinoamericana de Diabetes (ALAD)
Rosas-Saucedo, J., Caballero, A. E., Brito-Córdova, G. X., Bruce, H. G., Costa-Gil, J., Lyra, R., & Rosas-Guzmán, J. (2017) · Alad · doi:10.24875/alad.17000307 · Cited by 42
Are Performance Measures Necessary to Predict Loss of Independence in Elderly People?
Pedone, C., Costanzo, L., Cesari, M., Bandinelli, S., Ferrucci, L., & Incalzi, R. A. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv096 · Cited by 41
Hallan, S. I., & Orth, S. R. (2010) · Nephron Clinical Practice · doi:10.1159/000319166 · Cited by 41
Maximizing power in seroepidemiological studies through the use of the proportional odds model
Capuano, A. W., Dawson, J. D., & Gray, G. C. (2007) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2007.00014.x · Cited by 41
Wise, P. H. (2009) · PEDIATRICS · doi:10.1542/peds.2009-1100h · Cited by 41
Sufficient dimension reduction for longitudinally measured predictors
Pfeiffer, R. M., Forzani, L., & Bura, E. (2011) · Statistics in Medicine · doi:10.1002/sim.4437 · Cited by 41
Yang, Q., Liu, T., Valdez, R. A., Moonesinghe, R., & Khoury, M. J. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq026 · Cited by 41
Gupta, A., Hoang, D. D., Karliner, L., Tice, J. A., Heidenreich, P. A., Wang, P. J., & Turakhia, M. P. (2012) · American Heart Journal · doi:10.1016/j.ahj.2011.11.021 · Cited by 41
Ivert, A., Gracia, E., Lila, M., Wemrell, M., & Merlo, J. (2019) · European Journal of Public Health · doi:10.1093/eurpub/ckz162 · Cited by 41
Predicting cardiovascular events with coronary calcium scoring
Weintraub, W. S., & Diamond, G. A. (2008) · New England Journal of Medicine · doi:10.1056/nejme0800676 · Cited by 40
So, H., & Sham, P. C. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001230 · Cited by 40
Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis
Chen, F.-C., Xu, Y., & Zhang, Z. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000049 · Cited by 40
Subramanian, J., & Simon, R. M. (2010) · Statistics in Medicine · doi:10.1002/sim.4106 · Cited by 40
Poly-bagging predictors for classification modelling for credit scoring
Louzada, F., Anacleto-Junior, O., Candolo, C., & Mazucheli, J. (2011) · Expert Systems with Applications · doi:10.1016/j.eswa.2011.04.059 · Cited by 40
Mühlenbruch, K., Heraclides, A., Steyerberg, E. W., Joost, H., Boeing, H., & Schulze, M. B. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9744-0 · Cited by 40
Assessing the incremental role of novel and emerging risk factors.
Cook, N. R. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0084-x · Cited by 39
“[28] showed that a predictor or set of predictors needs an odds ratio as high as 16 per 2 standard deviations to lead to a high AUC.”
BackgroundGhith, N., Wagner, P., Frølich, A., & Merlo, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148187 · Cited by 39
Keller, P., Pagano, S., Roux-Lombard, P., Sigaud, P., Rutschmann, O., Mach, F., Hochstrasser, D., & Vuilleumier, N. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02479.x · Cited by 39
Zoccali, C., Tripepi, R., Torino, C., Tripepi, G. L., & Mallamaci, F. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv241 · Cited by 39
Mulinari, S., Bredström, A., & Merlo, J. (2015) · European Journal of Public Health · doi:10.1093/eurpub/ckv099 · Cited by 39
Wang, F., Pan, W., Pan, S., Wang, S., Ge, Q., & Ge, J. (2011) · Critical Care · doi:10.1186/cc10004 · Cited by 39
The Application of Genomics in Diabetes: Barriers to Discovery and Implementation
Floyd, J. S., & Psaty, B. M. (2016) · Diabetes Care · doi:10.2337/dc16-0738 · Cited by 39
Use of high density antibody arrays to validate and discover cancer serum biomarkers
Loch, C. M., Ramirez, A. B., Liu, Y., Sather, C. L., Delrow, J. J., Scholler, N., Garvik, B. M., Urban, N. D., McIntosh, M. W., & Lampe, P. D. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.08.004 · Cited by 39
Threshold somatic cell count for delineation of subclinical mastitis cases
Jadhav, P. V., Das, D. N., Suresh, K. P., & Shome, B. R. (2018) · Veterinary World · doi:10.14202/vetworld.2018.789-793 · Cited by 38
Sen, J., Huynh, Q. L., Stub, D. A., Neil, C., & Marwick, T. H. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.12.029 · Cited by 39
Genomic Clinical Trials and Predictive Medicine
Simon, R. M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139026451 · Cited by 38
The Role of the Mitochondrial Genome in Ageing and Carcinogenesis
Czarnecka, A. M., & Bartnik, E. (2011) · Journal of Aging Research · doi:10.4061/2011/136435 · Cited by 38
Glei, D. A., Goldman, N., Risques, R. A., Rehkopf, D. H., Dow, W. H., Rosero‐Bixby, L., & Weinstein, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152486 · Cited by 38
Individualized fracture risk assessment: State-of-the-art and room for improvement
Nguyen, T. V. (2018) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2018.03.001 · Cited by 39
Chapter 12: Systematic Review of Prognostic Tests
Rector, T. S., Taylor, B. C., & Wilt, T. J. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1899-y · Cited by 37
Ljungman, H., Wemrell, M., Khalaf, K., Vicente, R. P., Leckie, G., & Merlo, J. (2021) · Scandinavian Journal of Public Health · doi:10.1177/1403494821993723 · Cited by 37
Chuang, H., Hsu, J., Wang, C., Chuang, L., Chen, M., Chen, N., Huang, Y., Li, H., & Lee, L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189602 · Cited by 37
How good are we at predicting the fate of someone with acute myeloid leukaemia?
Estey, E. H., & Gale, R. P. (2017) · Leukemia · doi:10.1038/leu.2017.56 · Cited by 37
Määttä, M., MACDONALD, H. M., Mulpuri, K., & McKay, H. A. (2015) · Osteoporosis International · doi:10.1007/s00198-014-2994-9 · Cited by 36
Comorbidity does not predict long-term mortality after total hip arthroplasty
Bülow, E., Rolfson, O., Cnudde, P. H. J., Rogmark, C., Garellick, G., & Nemes, S. (2017) · Acta Orthopaedica · doi:10.1080/17453674.2017.1341243 · Cited by 36
A Bayesian Comparison of Frailty Instruments in Noncardiac Surgery: A Cohort Study
McIsaac, D. I., Aucoin, S. D., & van Walraven, C. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005290 · Cited by 36
Liu, L., Meng, Q., Weng, C., Lu, Q. L., Wang, T., & Wen, Y. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010328 · Cited by 36
The rules remain the same for genomic medicine: The case against “reverse genetic exceptionalism”
Evans, J. P., Burke, W., & Khoury, M. J. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181deb308 · Cited by 36
Cust, A. E., Goumas, C., Vuong, K., Davies, J. R., Barrett, J. H., Holland, E. A., Schmid, H., Agha‐Hamilton, C., Armstrong, B. K., Kefford, R. F., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-406 · Cited by 36
Network-Based Identification of Biomarkers Coexpressed with Multiple Pathways
Guo, N. L., & Wan, Y. (2014) · Cancer Informatics · doi:10.4137/cin.s14054 · Cited by 36
Marca, S. D., Cilia, C., Campagna, A., D’Arrigo, G., ElHafeez, S. A., Tripepi, G. L., Puccia, G., Pisano, M., Mastrosimone, G., Terranova, V., et al. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13459 · Cited by 36
Tool to Assess Likelihood of Fasting Glucose ImpairmenT (TAG-IT)
Koopman, R. J., Mainous, A. G., Everett, C. J., & Carter, R. E. (2008) · The Annals of Family Medicine · doi:10.1370/afm.913 · Cited by 36
Höfling, H., & Tibshirani, R. J. (2008) · The Annals of Applied Statistics · doi:10.1214/07-aoas152 · Cited by 37
Petrosino, M., Bogossian, E. G., Rebora, P., Galimberti, S., Chesnut, R. M., Bouzat, P., Oddo, M., Taccone, F. S., Citerio, G., & ORANGE Participants and Investigators (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.4189 · Cited by 35
Herder, C., Schöttker, B., Rothenbacher, D., Roden, M., Kolb, H., Müller, H., & Brenner, H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.041 · Cited by 35
Eckard, T. G., Padua, D. A., Mauntel, T. C., Frank, B. S., Pietrosimone, B., Begalle, R. L., Goto, S., Clark, M., & Kucera, K. L. (2018) · Physical Therapy in Sport · doi:10.1016/j.ptsp.2018.10.009 · Cited by 36
Sastre, B. E., Campillo-Artero, C., Ruiz, Y. G., Atuán, R. L. F., Rodríguez, P. B., Juan, G. F., & Romero, J. G. (2019) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2019.07.001 · Cited by 35
Assessing risk in chronic kidney disease: a methodological review
Grams, M. E., & Coresh, J. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.248 · Cited by 35
Tziakas, D. N., Chalikias, G. K., Stakos, D., Tentes, I. K., Papazoglou, D., Thomaidi, A., Grapsa, A., Gioka, G., Kaski, J. C., & Boudoulas, H. K. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.02.022 · Cited by 37
Ristow, B., Ali, S., Na, B., Turakhia, M. P., Whooley, M. A., & Schiller, N. B. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.01.019 · Cited by 35
Genome-Wide Association Studies Will Unlock the Genetic Basis of Hypertension
Kurtz, T. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.156190 · Cited by 36
Validation of continuous clinical indices of cardiometabolic risk in a cohort of Australian adults
Carroll, S. J., Paquet, C., Howard, N. J., Adams, R. J., Taylor, A. W., & Daniel, M. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-27 · Cited by 34
Genetic profiling and individualized assessment of fracture risk
Nguyen, T. V., & Eisman, J. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.3 · Cited by 34
Office blood pressure or ambulatory blood pressure for the prediction of cardiovascular events
Mortensen, R. N., Gerds, T. A., Jeppesen, J., & Torp-Pedersen, C. T. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx464 · Cited by 34
Reconsidering lactate as a sepsis risk biomarker
Moran, J. L., & Santamaria, J. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185320 · Cited by 35
Martens, F. K., Tonk, E. C. M., & Janssens, A. C. J. W. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0058-9 · Cited by 34
Lee, S., Ahn, W., Seweryn, M. T., & Sadée, W. (2018) · BMC Genomics · doi:10.1186/s12864-018-5219-3 · Cited by 34
Femoral Plaque Echogenicity and Cardiovascular Risk in Claudicants
Schiano, V., Sirico, G., Giugliano, G., Laurenzano, E., Brevetti, L., Perrino, C., Brevetti, G., & Esposito, G. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.01.011 · Cited by 34
Coley, R. Y., Fisher, A., Mamawala, M. K., Carter, H. B., Pienta, K. J., & Zeger, S. L. (2016) · Biometrics · doi:10.1111/biom.12577 · Cited by 34
Pierre, S. (2011) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328342fd86 · Cited by 34
Musunuru, K., Ingelsson, E., Fornage, M., Liu, P. X., Murphy, A. M., Newby, L. K., Newton‐Cheh, C., Perez, M. V., Voora, D., & Woo, D. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/hcg.0000000000000037 · Cited by 34
Metadata
- Authors
- Pepe, M. S.
- Affiliations
- Fred Hutch Cancer Center (US)
- Corresponding author
- Pepe, M. S.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 159
- Issue
- 9
- Pages
- 882-890
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2121514893
- Cited by
- 1,276
- References
- 27
- Citations by year
- 2026: 56 · 2025: 44 · 2024: 21 · 2023: 35 · 2022: 39 · 2021: 46 · 2020: 46 · 2019: 46 · 2018: 68 · 2017: 63 · 2016: 69 · 2015: 69 · 2014: 72 · 2013: 73 · 2012: 82
- FWCI
- 41.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (U01CA86368, U01CA074794, P01 CA18029, U01CA086368, P01CA018029)
- National Institute of General Medical Sciences (R01 GM 54438, R01GM054438)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- odds ratio, diagnostic biomarkers, prognostic factors, screening marker, receiver operating characteristic, classification accuracy, false positives, true positives, logistic regression, association measures
- MeSH terms
- Classification, Data Interpretation, Statistical, Epidemiologic Methods, False Positive Reactions, Humans, Mass Screening, Predictive Value of Tests, Prognosis, Risk Factors, ROC Curve, Reproducibility of Results, Biomarkers, Discriminant Analysis, Logistic Models, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.